Telotristat Etiprate Achieves Positive Top-Line Results In Second Phase 3 Clinical Trial, Met Primary Endpoint

By: via Benzinga
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that top-line data from its TELECAST Phase 3 study showed results of ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.